Yuejun Luo
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Development and validation of a biopsy-based model using tumor-associated neutrophils to predict neoadjuvant chemotherapy response in osteosarcoma: a large single-center retrospective cohort study.
Journal: Journal of bone oncology
Published: February 20, 2026
Prognostic and Predictive Value of CD163+ Macrophages for Neoadjuvant Chemotherapy in Osteosarcoma.
Journal: Biomedicines
Published: February 14, 2026
Trimodal, uncertainty-guided whole-slide framework for genome-scale spatial expression and image-only virtual perturbation in cancer cohorts.
Journal: Genome medicine
Published: October 15, 2025
Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer.
Journal: Journal for immunotherapy of cancer
Published: September 26, 2025
Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer.
Journal: Molecular biomedicine
Published: June 20, 2024
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 19, 2023
Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs.
Journal: Biomedicines
Published: January 25, 2023
Profile of treatment-related adverse events of PD-1 blockade-based therapies in advanced esophageal cancer: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: November 20, 2022
Comprehensive analyses of N6 -methyladenosine-related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer.
Journal: Cancer science
Published: May 21, 2022
A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma.
Journal: Journal of translational medicine
Published: April 06, 2022
Nivolumab plus ipilimumab: a potential regimen to rewrite treatment guidelines for ESCC.
Journal: Signal transduction and targeted therapy
Published: March 28, 2022
The potential role of N7-methylguanosine (m7G) in cancer.
Journal: Journal of hematology & oncology
Published: March 28, 2022
Last Updated: 09/26/2026